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The Changing Management of Acute Bronchitis in
Britain, 1940–1970: The Impact of Antibiotics
JOHN T MACFARLANE and MICHAEL WORBOYS*
It has become commonplace in accounts of medicine in the second half of the twentieth-
century to ascribe an ‘‘antibiotic revolution’’ to the years when penicillin became widely
available from the early 1950s. However, to date there have been hardly any studies that
demonstrate a major discontinuity in medical practices after mid-century, let alone that go
on to specify their character.
1 There would seem to be two key features of any ‘‘antibiotic
revolution’’: first and foremost that the treatment of diseases was transformed as doctors
were able to cure illness caused by infections with specific drugs that eliminated causative
bacteria; and second that the ambition of doctors to intervene with drugs in a number of
diseases grew, as did the ability of the pharmaceutical industry to supply an increasing
range of targeted and effective remedies.
2 In this article we contribute towards an assess-
ment of the first of these key features by discussing the changing management of acute
bronchitis from the mid-1940s to the early 1960s. The disease was amongst the most
prevalent and important of that period in Britain, being the single largest cause of con-
sultations with general practitioners (GPs) through much of the 1950s. Bronchitis was also
the subject of many high profile debates among doctors and health care agencies as
concerns about its morbidity and mortality touched on such issues as smoke pollution,
the costs of the National Health Service (NHS) and changes in the doctor–patient relation-
ship. The evidence of contemporary studies shows that the treatment of acute bronchitis
changed radically after the introduction of antibiotics, such that by the mid-1950s over
80 per cent of patients diagnosed with the condition were prescribed penicillin or another
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47antibacterial drug—a shift that was not supported by any clinical trials or systematic
evidence.
3 How and why this change occurred are the questions we set out to answer.
As well as addressing the specific issue of the impact of antibiotic therapy on the
management of a single disease, our analysis also illuminates three other larger themes.
Firstly,theaetiology,pathologyandmanagementofacutebronchitiswasalreadycontested
in the 1940s, and this situation was further destabilized by antibiotics, so we have neces-
sarily explored the changing medical constructions of the disease. Secondly, the introduc-
tion and widespread use of antibiotics coincided with the establishment of the NHS, so we
also consider the inter-relations between changes in clinical practice and the new health
care structures and policies after 1948. Finally, our discussionisrelevant to current clinical
practice becausechest illnesses, such asacute bronchitis,remain the commonest reason for
GP consultation in Britain, and most cases continue to be treated with antibiotics, even
thoughevidencesuggeststhatthesedrugsdolittletoaffectthenaturalhistoryoftheillness,
which is normally self limiting.
4 Thus, it is likely that the legacy of the use and probable
overuseofantibioticsforacutebronchitis,whichemergedsostronglyduringthe1950s,has
contributed substantially to the current alarming problems of antibiotic resistance, as well
to the proliferation of side effects and the rising costs of health care.
5
We begin by discussing the prevalence and importance of acute bronchitis from the late
1940s to the early 1960s and highlight the fact that the British were a particularly ‘‘chesty’’
nation and that this chestiness was mainly attributed to climate and the urban industrial
environment. In this context, it is important to recognize that acute bronchitis was seen as
infective rather than infectious; that is, bacteria were understood to be opportunistic,
secondary infective agents of bronchi that had been inflamed by other physical, chemical
and biological agents. Our discussion then moves on to look briefly at the public profile of
the disease and the advice given to the public by doctors and the press. We identify three
phases in the changing advice offered to doctors in published sources: a pre-antibiotic
period in the 1940s; a period from the late 1940s to the mid-1950s when antibiotics were
recommended only for complications and serious disease; and finally a period from the
late-1950s when antibiotics were recommended for all cases of the disease. Finally, we
analyse the influence of three non-clinical factors on the management of the disease: the
structures and policies of the NHS; the pharmaceutical industry; and public pressures.
Acute Bronchitis in Britain in the 1950s
Leading medical textbooks in the late 1940s and early 1950s characterized acute bron-
chitis as a common, self-limiting but inconvenient illness, arising as a result of exposure to
cold or to sudden changes in temperature or inhalation of irritating dusts or vapours
3College of General Practitioners (CGP), ‘Acute
chest infection in general practice. A group
investigation by 55 general practitioners organizedby
theresearchcommitteeofthecounciloftheCollegeof
General Practitioners’, Br. med. J., 1956, i: 1516–20,
p. 1518.
4Scottish Intercollegiate Guidelines Network
(SIGN), ‘Community management of lower
respiratory tract infection in adults’, 2002, 59: 1–29.
Accessed by http://www.sign.ac.uk/guidelines;
Patient-Orientated Evidence that Matters (POEM),
‘Antibiotics are not needed for lower respiratory tract
infection’, Br. med. J., 20 Aug. 2005, 331: 0NN.
5 M Woodhead, D Fleming, R Wise, ‘Antibiotics,
resistance and clinical outcomes’, Br. med. J., 2004,
328: 1270–71.
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infection, or less commonly as primary irritating agent.
6 The illness often started with
catarrh or common cold symptoms and progressed to constitutional upset, fever, irritating
dry cough, wheezing and rawness in the throat, and retrosternal discomfort. After a few
days sputum production developed, and became copious and often discoloured (purulent).
Mild fever of 100–103F was common and in the chest, bilateral wheezes and crackles
were the main diagnostic indicators. The presence of variable bilateral signs in the chest
was seen as important in differentiating the illness from pneumonia, when the signs were
usuallyone-sided.Thesymptomsthengraduallysettledspontaneously,although thecough
oftenextendedforthreeorfourweeks.Chronicbronchitiswasdistinguishedfromtheacute
form by the absence of fever and pain, and a persistent and distinctive daily pattern of
coughing phlegm.
7
Such descriptions reveal that the diagnosis of acute bronchitis was made not by X-ray
or laboratory tests, but by clinical judgement, based on the presence of a constellation of
common signs and symptoms—principally a cough—that were shared by many other
syndromes such as the common cold, simple cough, influenza and upper respiratory
infections. The Chief Medical Officer, Dr J A Charles, in his 1958 annual report, devoted
a whole section to the importance of the common respiratory diseases and the difficulty
of diagnosing clinical syndromes such as bronchitis, pneumonia, influenza and upper
respiratory infections in primary care, stating:
The differentiation on clinical grounds of ‘‘influenza’’, for example, from other acute febrile
respiratory illnesses is often quite arbitrary. This arises not so much from any defect of clinical
judgment in individual cases as from the very nature of this group of illnesses, which present many
gradations and combinations of symptoms ...
8
The Research Committee of the College of General Practitioners noted there were over 150
synonyms of acute respiratory infections, and that any classification based on identifying
specific causes or the seat of the disease was near impossible in general practice.
9
In the late 1940s, respiratory illness, particularly bronchitis, was by far the commonest
reason for consultations with GPs, accounting for 41 per cent in the winter and 21 per
cent in the summer in one urban practice.
10 There was concern amongst employers and
the government about working days lost, for example, in 1950–51 bronchitis was sur-
passed only by influenza as the reason for absence.
11 Bronchitis was the commonest
reason for GPs to issue sickness certificates, with 29 per cent of all certificates in
1953 being due to respiratory diseases.
12 When Drs John and Elizabeth Horder, a
husband-and-wife partnership, recorded the reasons for consultation in their general
practice in London in 1954, bronchitis topped the list in the winter ahead of the common
6The important contribution of viruses did not
emerge until the 1960s.
7Chronic bronchitis: an NAPT symposium,
London, NAPT, 1958.
8National Archives, Public Records Office
(hereafter NA PRO) MH 132/48, Report of the
Minister of Health for the year ending 1958. Part 11.
On the state of the public health, being the annual
report of the Chief Medical Officer, London, HMSO,
Nov. 1959, p. 73.
9CGP, op. cit., note 3 above, p. 1518.
10J Pemberton, ‘Illness in general practice’, Br.
med. J., 1949, i: 306–7.
11The Times, 16 Sept. 1955, p. 7.
12Anon., ‘Facts from general practice’, Lancet,
1953, ii: 978–9.
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13 A study in 1956 estimated that there were one million sufferers of acute chest
infections, including acute bronchitis, in Britain each year.
14 Between 1950 and 1951,
one north-west London general practice reported that between 20 and 40 per cent of the
work of the practice consisted of acute respiratory infection; most cases were not serious,
but three-quarters of them were given a prescription.
15 Such studies showed that acute
bronchitis affected not only the older patients, but was a surprisingly common cause of
consultation in younger adults, especially women, with younger and middle-aged women
consulting twice as often as men.
16 This high consultation and prescription rate for acute
bronchitis is perhaps unsurprising, as its cardinal feature is a cough, and coughs are very
common and often irritating enough to trigger a visit to the GP. As late as 1974, a two-
week random survey found that coughs and sputum affected one-third of British adults.
17
The Public and Acute Bronchitis in the 1950s
The profile of the disease was maintained in the public sphere by its frequent mention as
a cause ofillness inthe rich and famous. Not infrequently, membersof parliament or social
figures were reported to be ‘‘consigned to bed with a sharp attack of bronchitis’’ in the
Court Circular and News in Brief sections of The Times. The Maharaja of Indore was noted
to be convalescing after a mild attack of bronchitis in July 1947 and Boo-Boo II, London
Zoo’s oldest chimpanzee died suddenly of acute bronchitis on 14 January 1949.
18
Dr Fisher, the Archbishop of Canterbury was unable to take the service at the funeral
of King George VI on 11 February 1952 being ‘‘confined to his room at Lambeth Palace
with bronchitis’’—the Archbishop of York presided instead.
19 The public may also have
been encouraged to see coughs as being caused by bacteria by the change in the Ministry
of Health ‘‘coughs and sneezes spread diseases’’ poster campaign, with the medicalized
1951 version (Figure 1) showing culture plates covered in bacterial colonies from some-
one’s cough and sneeze, compared with the more cartoon style one for 1941 (Figure 2).
The public were made aware of the potential seriousness of bronchitis by many autho-
rities.In1955,TheTimesechoedtheviewsofthemedicalprofession,indicatingbronchitis,
the common cold and influenza as three of the five conditions that caused the greatest
burden‘‘upontheindividual,theemployer,thecommunityandthedoctor’’.
20Pressreports
during influenza outbreaks emphasized the significant death rate from bronchitis and
pneumonia; for example, The Times reported that in Liverpool in January 1951 the
death rate had quadrupled, mostly due to bronchitis and pneumonia after influenza.
21
13J Horder and E Horder, ‘Illness in general
practice’, Practitioner, 1954, 173: 177–87, p. 186.
14CGP, op. cit., note 3 above, p. 1518.
15E M Backett, J A Heady, J C G Evans, ‘Studies
of a general practice (II). A doctor’s job in an urban
area’, Br. med. J., 1954, i: 109–15, p. 113.
16This pattern was confirmed by the General
Register Office 1952–1954 study of 37,000
consultations.
17J Fry, Common diseases: their nature,
incidence, and care, Lancaster, Medical and
Technical Publishing, 1974, ch. 2 ‘Influenza’,
pp. 16–26.
18 TheTimes,12Jul.1947,p.6;15Jan.1949,p.3.
19The Times, 11 Feb. 1952, p. 6.
20The Times, 16 Sept. 1955, p. 7.
21The Times,17 Jan. 1951, p. 2. Dr John Fry, a GP
from Beckingham, who was a pivotal figure in the
earlydaysofprimarycareresearchandpublishedwidely
on acute bronchitis and chest infections, put it another
way, ‘‘‘flu’ can become a convenient garbage-can type
oflooseandimprecisediagnostictermthatoffersaquick
andreadylabelforthevictimsofamultitudeofcommon
respiratoryinfections’’.Fry,op.cit.,note17above,p.22.
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John T Macfarlane and Michael WorboysIn 1954, the British Medical Association’s (BMA) Family Doctor magazine published
an article, responding to what doctors saw as unnecessary consultations, which
discussed when a patient should see their GP when troubled by flu or a cough. The
author suggested ‘‘don’t bother him and make him more overworked. Far better to
Figure 1: Ministry of Health poster, London, HMSO, 1951 (NA PRO BN10/218).
51have the smug satisfaction of curing yourself.’’
22 The press also highlighted the dangers
of bronchitis during the winter smogs.
23 The Chief Medical Officer reported that the
London fog of 5–8 December 1952 resulted in 3500 to 4000 excess deaths, mostly due
to bronchitis, and in one week the bronchitis death rate increased ninefold.
24
Figure 2: Ministry of Health poster, London, HMSO, 1941 (NA PRO BN10/218).
22‘All about ‘flu’, Family Doctor, 1954, 4: 84–5,
p. 84.
23The Times, 31 Jan. 1953, p. 3.
24NA PRO MH 132/36, Report of the Minister of
Health for the year ending 31 Dec 1952. Part 11. On
the state of the public health, being the annual report
of the Chief Medical Officer for the year 1952,
London, HMSO, Dec 1953, p. 76.
52Advice on the Management of Acute Bronchitis
Acute bronchitis was mostly treated by GPs, with relatively few cases going to
hospital. This situation highlighted a problem that the government and the profession
wrestled with in the 1950s; namely, that hospital-based medical education did not
prepare newly qualified doctors for general practice. There is no doubt that new GPs
brought both more up-to-date knowledge and hospital habits to primary care, as sub-
sequent studies showed younger GPs were more likely to prescribe antibiotics than their
more experienced, older partners.
25 However, young doctors entering general practice in
the late 1940s and 1950 had not been taught to deal with the plethora of often mild, self-
limiting and ill-defined illness seen in the consulting room. This was brought out in the
damning report in March 1950 on the state of general practice in England by the
Australian Dr Joseph Collings, which commented in particular on poor education,
standards and morale.
26 In one of many responses to the Lancet, Anthony Ryle, a
newly qualified doctor, wrote: ‘‘At present, medical education fails to give a balanced
view of the r^ ole of medicine. Taught entirely in well-equipped hospitals where patients,
isolated from their homes and jobs, are analysed in fine detail, medical students are but
distantly aware of the scope of general practice, and young doctors enter it ignorant of its
problems and unprepared for the effort required to maintain professional standards.’’
27
The BMA’s 1950 report on General practice and the training of the general practitioner,
had recommended three postgraduate training years including a year as a trainee with an
approved established general practitioner, but this was not instituted for several years.
28
In 1953, only Manchester and Edinburgh medical schools had units teaching the
principles of general practice to their medical students.
29 Thus, newly qualified
doctors entering general practice during the 1950s had to depend upon their hospital
training and textbooks, and, because of the absence of professional updating, they, like
their more experienced colleagues, also relied upon the medical press, prescribing for-
mulae and information from pharmaceutical representatives to learn of new develop-
ments. Concerns about the inappropriate training of doctors going into general practice
were highlighted as late as 1962 when a report in The Times, under the headline ‘Student
doctor baffled by influenza. Training criticized’, reported the complaints of a GP that
young doctors had never seen cases of bronchitis or influenza.
30 This article tracks the
changing ideas about the management of acute bronchitis through the many editions of
widely used textbooks, the National Formulary and Prescribers’ Notes.
31 Later we also
discuss the nature and influence of pharmaceutical companies’ promotional activities.
Clearly individual doctors made their own choices and there were wide variations in the
25J G R Howie, I M Richardson, G Gill, D Durno,
‘Respiratory illness and antibiotic use in general
practice’, J. R. Coll. General Practitioners, 1971, 21:
657–63.
26J S Collings, ‘General practice in England
today’, Lancet, 1950, i: 555–85.
27Anthony Ryle, letter to the Lancet, 1950,
i: 885.
28British Medical Association, General practice
and the training of the general practitioner, London,
British Medical Association, 1950, pp. 82–4; P A
Tyser,‘Trainingforgeneralpractice’,Lancet,1950,i:
1091.
29GRivett,Fromcradletograve:fiftyyearsofthe
NHS, London, King’s Fund, 1998, p. 90.
30The Times, 24 Oct. 1962, p. 15.
31 We have been unable to track down any
extant copies of Prescribers’ Notes. It was
produced between 1952 and 1958 and was the
forerunner of the Prescribers’ Journal, which
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GP leaders, the Council of the College of General Practitioners commenting to the
Hinchcliffe Committee, ‘‘We believe it should be left to the doctor in change of a
case to use his discretion concerning use of drugs’’.
32 However, they also recommended
an independent body to assess new drugs and advise doctors on appropriate prescribing
of these, and as a result all GPs were sent free the Prescribers’ Journal, an independent
regular publication, as well as the National Formulary.
33 Indeed the first eight editions of
the Prescribers’ Journal included nine chapters on antibiotics and three on respiratory
tract infections, emphasizing the importance that was increasingly given to appropriate
antibiotic prescribing by GPs. In addition, the Medical Letter was produced by the
Consumers’ Association of England from 1962 as a non-profit making publication
with advice on drugs and therapeutics, but it cost GPs three guineas per year.
Before Antibiotics
The 1944 edition of the Textbook of medical treatment devoted eleven pages to acute
bronchitis, concentrating on symptomatic management of the patient, with detailed
advice on bed rest in a warm well-ventilated room, a light diet, the use of steam
inhalations, local heat poultices to the chest, special woollen and flannel bed wear,
medicines to suppress cough or aid expectoration, and sedatives.
34 Oxygen and even
blood-letting were suggested, with 10 to 20 oz of blood advised for more severe cases.
Convalescence of two to four weeks before returning to work was recommended, and
this was to include sunshine, a change of air and scenery, good nourishing food and
breathing exercises morning and evening. Better-off patients were urged to take a holi-
day at the seaside. Such a regime demanded considerable commitment of time, effort and
resources from the patient, his or her family and medical practitioner. The only specific
therapy mentioned was the use of sulphonamides for treating complications. Doctors
worried that acute bronchitis could lead to pneumonia, a condition greatly feared in the
profession and by the public.
35 The 1946 eighteenth edition of Black’s medical dic-
tionary warned of the potential for the inflammation to spread into the small bron-
chial tubes or the lung causing capillary bronchitis or pneumonia, particularly in the
young, the elderly or those with underlying disease or ‘‘addicted to intemperance’’.
36
Sulphonamides were antibacterial chemotherapeutic agents that had been introduced in
replaced it in 1961 on the recommendation of the
Hinchcliffe Committee. See, Department of Health,
Final report of the Committee on Cost of Prescribing,
HinchcliffeCommitteereport,London,HMSO,1959,
p. 49.
32Royal College of General Practitioners,
Archives (hereafter RCGPA), ACE J8–1, The cost of
prescribing. A memorandum from the Council of the
College of General Practitioners, 1958, p. 3.
33Ibid., p. 4.
34D M Dunlop, L S P Davidson, J W McNee,
Textbook of medical treatment, 3rd ed., Edinburgh,
Livingstone, 1944, pp. 861–71.
35A B Christie, ‘Refresher course for general
practitioners: acute bronchitis’, Br. med. J., 1951, i:
82–5.
36J D Comrie, H A Clegg, Black’s medical
dictionary, 18th ed., London, Adam and Charles
Black, 1946, pp. 145–9.
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John T Macfarlane and Michael Worboysthe mid-1930s. At that time, hopes for chemotherapy to treat infections were at a low
ebb, science having failed to live up to Paul Ehrlich’s prediction at the turn of the century
that researchers should be able to produce ‘‘magic bullets’’ that would kill disease germs
but leave host cells unharmed. Although sulphonamides were effective against a rela-
tively small number of bacteria, such as those causing puerperal fever, erysipelas and
pneumonia, where they had replaced serum therapy, they did alter the prospects for
antibacterial therapy and were one factor that had prompted the search for new anti-
biotics in the late 1930s.
37
Strict bed rest had been the traditional management for bronchitis for decades, but was
criticized by Derek Dunlop, professor of therapeutics at Edinburgh University in his 1949
address to the Nottingham Medico-Chirurgical Society entitled ‘Modern concepts in
therapeutics’.
38 In attacking many of the fads and fashions of the previous fifteen
years he asserted, ‘‘bed rest should be ordered with the same care as one would prescribe
a dangerous drug’’. Similarly Thomas Anderson, a Reader in infectious diseases at the
University of Glasgow, stressed in 1952 the importance of early mobilization for the
elderlywithacutebronchitisas‘‘itincreasesthedepthofrespiration,enhancesthecapacity
to cough and so to clear the respiratory passages and, in most cases, produces a marked
mental stimulation of the patient’’.
39
The National War Formulary of 1941 produced by the Ministry of Health to advise
doctors on prescribing emphasized the importance of austerity in all aspects of drug use,
commenting that use was ‘‘justified only if the drugs are required for essential medical
purposes. Many important substances are available in but limited amounts for medicinal
purposes. They are more urgently required for other branches of the nation’s war effort’’.
40
By 1947 some relaxation was evident in the third edition, although caution in prescribing
was required to ‘‘assist the nation’s economic recovery’’, which had been hit by a parti-
cularly severe winter.
41
Antibiotics for Patients with Severe Disease
The 1949 edition of the Textbook of medical treatment advised the use of penicillin—
the ‘‘miracle drug’’—alongside sulphonamides, as the most important life-saving inter-
ventions in acute bronchitis. The wider therapeutic optimism regarding penicillin was
reflected in the statement that it was ‘‘one of the most satisfying drugs in medicine ...
37M Worboys, ‘Treatments for pneumonia in
Britain, 1910–1940’, in I Lo ¨wy (ed.), Medicine
and change: historical and sociological studies
of medical innovation, Montrouge, John Libbey
Eurotext; and Paris, INSERM, 1993, pp. 317–26;
I Loudon, ‘Puerperal fever, the streptococcus, and
the sulphonamides, 1911–1945’, Br. med. J., 1987,
295: 485–9.
38Christie, op. cit., note 35 above, p. 84.
University of Nottingham Hallward Library
manuscripts and special collections material
(hereafter UNHL) MCH 1/10/1, Minutes of the
address by Professor Sir Derrick Dunlop to the
Nottingham Medico-Chirurgical Society on ‘Modern
concepts in therapeutics’, on 30 Nov. 1949,
pp. 116–17.
39T Anderson, ‘The newer antibiotics in
respiratory infections’, Practitioner, 1952, 169:
589–95, p. 592.
40Ministry of Health, National War Formulary,
1st ed., London, HMSO, 1941, p. 5.
41Ministry of Health, National [War] Formulary,
2nd ed., London, HMSO, 1947, p. 5.
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no longer justification for withholding it in susceptible infections’’.
42 The first edition
of Stanley Davidson’s The principles and practice of medicine in 1952 devoted four
pages to acute tracheo-bronchitis, with a sulphonamide (sulphadimidine) or injectable
penicillin being recommended in the presence of fever, particularly in the elderly or
those with other diseases.
43 Similar advice had been given in the 1954 edition of Maurice
Davidson’s A practical manual of diseases of the chest. This provided detailed advice on
symptomatic remedies, bed rest, fluid intake and diet—two hourly feeds of a mixture of
milk, Bovril, raw egg, sugar and brandy; however, there was only one mention of anti-
biotics,‘‘insomecasesadministrationofthe newer chemotherapeutic agentsmaybecalled
for’’ in severe infection, when early venesection and oxygen therapy were also seen as
being valuable.
44
The Penicillin Act of 1947 had restricted penicillin supply to doctor prescription
only but the variety of preparations on offer may have encouraged use by GPs, and the
publicity surrounding penicillin raised patient expectations. The preferred mode of admin-
istration was by intramuscular injection, and, as penicillin was rapidly excreted from the
body, these needed to be repeated several times each day. There were two oral forms
available, but at this time these were poorly absorbed and could not be relied upon
in serious conditions. Penicillin was also available as a powder or a solution for inhalation
for treating chest infections (‘‘Nebula penicillini’’). The use of inhaled penicillin had
become popular in general practice in the late 1940s, particularly in the USA, for treating
sinusitis, bronchitis and pneumonia. In 1948 the Reader’s Digest published an article
which recommended penicillin mist as ‘‘the treatment by far the simplest, safest and
most effective yet devised for sinus infections’’.
45 Dr A Christie recommended inhaled
penicillin as the treatment of choice for acute bronchitis in a refresher course for
GPs.
46 However, providing a means of inhalation (by nebulizer, atomizer or pressured
oxygen)wasinconvenientforpatientanddoctor,andtheproblemofsorethroatalsosawits
popularity wane. Local treatment was available using penicillin lozenges, toothpaste or
chewing gum (with the trade name ‘‘Chulin’’) for sore throats, different forms of penicillin
ointment and cream for the skin, and drops for ear, nose and eye inflammation. Miscella-
neous products included penicillin tulle, dusting powder, suppositories, pessaries and even
penicillin earplugs, using cocoa butter as the base.
While acute bronchitis was typically regarded as a minor ailment—a ‘‘shower’’—it
was often seen as a precursor of pneumonia—a ‘‘storm’’. The serious nature of pneu-
monia meant that many patients were hospitalized, hence, much of the expertise on the
use of penicillins in such cases was held by hospital physicians. The 1951 Textbook of
medicine emphasized the difficulties of making a diagnosis and noted most physicians
42D M Dunlop, L S P Davidson,
J W McNee (eds), Textbook of medical treatment,
5th ed., Edinburgh, Livingstone, 1949, pp. 86–8,
on p. 86.
43L S P Davidson, The principles and practice of
medicine: a textbook for students and doctors, 1st ed.,
Edinburgh, Livingstone, 1952, pp. 58–61.
44Maurice Davidson, A practical manual of
diseases of the chest, London, Geoffrey Cumberlege,
Oxford University Press, 1954, p. 117.
45Miller, ‘Penicillin mist for sinus trouble’,
Readers’ Digest, April 1948: 59–61.
46See Christie op. cit., note 35 above, pp. 82–5.
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John T Macfarlane and Michael Worboyswere in favour of giving either penicillin or sulphonamides for at least forty-eight hours
for chest infections, in case they were dealing with an undiagnosed pneumococcal or
streptococcal infection, switching to chloramphenicol or a tetracycline if there was no
improvement.
47 This illustrates another feature of practice during the 1950s that the
doctors would try first one and then a second antibiotic if recovery was not swift. This
move to sequential prescribing was self-perpetuating for a condition, the symptoms and
natural history of which were mostly uninfluenced by antibiotics. This may have been
triggered by the description of the primary atypical pneumonia syndrome. This was an
increasingly recognized entity by the early 1950s, being described in Davidson’s The
principles and practice of medicine in 1952 as presenting, not with the features of classic
bacterial lobar pneumonia, but more like acute bronchitis with prominent cough and
sparse signs on lung examination, and not responding to penicillin.
48 This concern with
primary atypical pneumonia as a common cause of chest infections highlights once again
the anxieties about pneumonia and wider concerns about the dangers of lung diseases,
although Professor Charles Stuart-Harris when speaking about pneumonia to the
Nottingham Medico-Chirurgical Society on 13 February 1952 estimated that only a
small number of cases were actually due to atypical infections.
49 Similarly, John Fry
reported having seen only fifty cases over a four-year period in general practice in spite
of his keen interest in chest infections.
50
The 1952 version of the National Formulary provided distinct encouragement to
penicillin prescribing, commenting that ‘‘Penicillin is now freely available and relatively
cheap ...It is remarkably free from toxic side-effects although allergic reactions are not
uncommon’’.
51 The cost had certainly dropped. In 1943 the price of a million units of
penicillin was $200, by the time of the invasion of Europe in 1944 it was $35, and by
1950 it had dropped to 50 cents.
52 Only two years later, the 1955 third edition of the
National Formulary was much more cautious about antibiotic use and discussed its pros
and cons with particular reference to the emerging problems of resistance, cost and side-
effects.
53 After an initial honeymoon period, side-effects were seen to be more of a
problem with the newer antibiotics. Intestinal upsets and fungal and bacterial over-
growths were being reported with tetracyclines, with the effect on children’s teeth
being noted later. Chloramphenicol, initially seen as such a valuable drug, was now
recommended only for serious conditions because of potentially fatal aplastic anaemia.
The marked safety of penicillin had given doctors and the public a false sense of security
about antibiotics in general, and there was some suggestion that knowledge about the
side effects of new antibiotics took time to spread into general practice. In a review of
chloramphenicol for the Practitioner in 1956, Professor Clifford Wilson from the
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ed., Philadelphia and London, Saunders, 1951, pp.
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49UNHL, MCH 1/11, Minutes of the address
by Professor Stuart-Harris to the Nottingham
Medico-ChirurgicalSociety,‘Pneumonia’,on13Feb.
1952, p.21.
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The Changing Management of Acute Bronchitis in Britain, 1940–1970London Hospital noted that, even though the enquiry the previous year had documented
numerous deaths from aplastic anaemia, up to 6000 kilograms of the antibiotic were still
being used in general practice.
54 Erythromycin resistance were developing so rapidly that
it was recommended only for penicillin-resistant staphylococcal infections. Injected
penicillin, available in five formulations, was regarded as cheap and safe, and remained
the preferred antibiotic for chest infections; whereas oral penicillin G was said to be
poorly absorbed and was five to ten times more expensive.
55
The reliance on administering penicillin by injection was significant. It meant that
such treatments were easier to deliver with hospital patients and much more difficult in
general practice because of the commitments required by doctor and patient. In 1955,
John Fry linked the abuse of antibiotics to the growing availability of oral penicillins and
advised that intramuscular injection was still the safest and most useful mode of admin-
istration in general practice, ensuring that it would be restricted to appropriate cases, ‘‘for
in my opinion any case which needs penicillin also requires daily medical supervi-
sion’’.
56 Inconvenient it certainly was. Injections between two and five times a day
were needed and strict guidelines were in place for sterilizing syringe and needle, and
storing penicillin solution in a refrigerator.
57 The injection was painful. One patient
wrote to the Family Doctor recalling the pain of six hourly penicillin injections and
commented, ‘‘the thought of future injections terrifies me’’.
58 Manufacturers of oral
antibiotics exploited the inconvenience to the GP of prescribing a course of penicillin
injections. An advert for penicillin G tablets in the British Medical Journal in 1953
contained the headline, ‘‘Freedom for a day!’’ and continued: ‘‘‘Come again tomorrow
for another penicillin injection’ ... tomorrow ... tomorrow ... how relentlessly those
‘tomorrows’ confine the doctor to a restricted programme ...given a supply of tablets
... the patient can easily carry out the treatment himself.’’
59 Other doctors saw oral
penicillin as little more than a placebo.
60 When speaking at a conference held at the
Royal Society of Medicine in November 1954, Dr Lindsay Batten reported the use of
oral penicillin as doubtful practice and an abuse, because of irregular absorption. She
recommended, ‘‘the ‘penicillin umbrella’ should be reserved for real impending storms
and not unfurled and hoisted at every threatened shower’’.
61
In the third edition of Davidson’s Principles and practice in 1956, the new oral
antibiotic tetracyclines, chloramphenicol or streptomycin were advised if clinical
improvement had not occurred after forty-eight hours of starting penicillin injections.
62
Sulphonamides were no longer mentioned. Penicillin was still mainly used for compli-
cations in severe cases, especially when fever was present and the aim was to ‘‘prevent’’
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John T Macfarlane and Michael Worboysthe extension of the infection.
63 Older methods of treatment persisted in some contexts,
for example, in 1958, Dr Kenneth Robson, a specialist from the Brompton Hospital, in a
review on acute bronchitis in the Practitioner in 1958 recommended a ‘‘good old-
fashioned steam tent ... The tent should be a comprehensive affair going right to
the foot of the bed, with a canopy like a fourposter’’.
64 He also commented that,
‘‘the sooner they [sufferers] give up work and accept the fact that getting well is
going to be their whole-time occupation for a week or so, the better’’.
65
Antibiotics for All Patients
The 1954 fourth edition of A practical manual of diseases of the chest similarly
cautioned, ‘‘It is ... a wise policy not to regard any case [of acute bronchitis], even
the mildest, too lightly, as the condition is potentially serious and may be followed by a
more extensive involvement of the respiratory passages with severe constitutional dis-
turbance.’’
66 At this time the aetiology of acute bronchitis and pneumonia were seen as
quite similar, both developing as a result of secondary opportunistic bacterial infection of
inflamed bronchial and lung tissues, hence treatment with antibiotics developed around
the idea of nipping such infections in the bud. Such a preventative strategy became
popular in general practice because accurate diagnosis, and differentiating bronchitis
from early bronchopneumonia, was difficult. This probably resulted in the labelling of
any cough or acute respiratory symptoms as acute bronchitis, with resultant over-
diagnosis, particularly at times of heavy workload during the winter ‘‘chesty cough’’
season, when GPs were quick to diagnose bronchitis and offer an antibiotic pres-
cription. An expert study group accepted the difficulty of differentiating uncomplica-
ted influenza from influenzal pneumonia in the home during the 1957/58 influenza
epidemic and recommended that patients over fifty and those with pre-existing car-
diac or respiratory disease should all be given a broad spectrum antibiotic such as
chlortetracycline.
67 Dr Alastair Mackinnon, a GP from Leeds, when recommending
early penicillin commented, ‘‘Today the general practitioner does not wait for the
development of the classical signs of pneumonia, or seek in his treatment to discriminate
between acute bronchitis and broncho-pneumonia ...his aim must be, in Montgomery’s
language, to hit the invading germs for six with his most potent weapons.’’
68 Such a
policy was recommended despite the evidence that only 7 per cent of patients with
acute chest infections were admitted to hospital (which in turn meant that hospital
doctors saw only a few severe cases) and that 88 per cent of illnesses ran an uncom-
plicated course.
69
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The Changing Management of Acute Bronchitis in Britain, 1940–1970Two main changes occurred with the Formulary in 1957. It was re-named the British
National Formulary and published in an alternative edition, produced by the Joint
Formulary Committee of the BMA and the Pharmaceutical Society of Great Britain.
Drugs were now grouped according to their purpose, to aid the GP in prescribing for
individual conditions, rather than just listed alphabetically to aid dispensing. Preparations
for the relief of cough featured prominently with fifteen mixtures and linctuses to suppress
cough, four preparations forinhalation (mainlybenzoin, menthol and eucalyptus mixtures)
to aid expectoration, and seventeen to relieve any spasm.
70 In the section on antibiotic
therapy, official concerns about the indiscriminate use of antibiotics were aired and it was
advised that, ‘‘In general it may be said that if the patient is ill enough to receive an
antibiotic he is ill enough to be in bed. Penicillin is still the antibiotic with the fewest side-
effects and should usually be the first choice.’’ It was also noted that ‘‘it is usually
preferable to give penicillin by injection [for adults].’’
71 Follow-up treatment with tetra-
cycline was recommended if patients with acute bronchitis (or pneumonia) did not respond
to penicillin. This firm advice to treat only patients ill enough to be in bed was somewhat
countered by the section on the respiratory system drugs which stated, ‘‘It should be
remembered that many coughs have a background of infection, and chemotherapy with
... antibiotics may be desirable.’’
72 This mixed message persisted in the 1960 edition
which also indicated that oral therapy was becoming more acceptable and certainly
easier; no less than twelve different proprietary preparations of oral penicillin were
now available, mostly variants of phenoxymethylpenicillin.
The 1964 edition of the Textbook of medical treatment made a clear link between acute
bronchitis and bacterial infection, stating ‘‘acute bronchitis is an acute inflammation of the
mucous membrane of the trachea and bronchi caused by bacterial infection’’, and now
recommended the newly available range of oral antibiotics, even in the absence of fever.
73
This contrasted with the second edition twenty years previously where acute bronchitis
was described only as an inflammation of the mucous membranes of the bronchi, with
predisposing causes including coryza and influenza.
74 By the mid-1960s, the antibiotic
options available to doctors had changed out of all recognition, with a choice of fifteen
oral penicillin preparations including names such as econocil, stabillin, and tonsillin.
Similarly, the 1966 edition of L S P Davidson’s book described acute bronchitis as
being caused by pyogenic bacteria, and antibiotics were firmly ensconced as appropriate
treatment whatever the symptoms, with the expectation that the condition was ‘‘usually
mildandofshortduration,thepatientrecoveringintwotothreedaysifasuitable antibiotic
is given’’.
75
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John T Macfarlane and Michael WorboysGPs were mainly interested in whether to prescribe antibiotics or not, while hospital
specialists were concerned with which antibiotic to use. This situation reflected the differ-
ences of both the clinical context and the doctor–patient relationship in general practice
andinthehospital.In1955AnthonyBattyShawandJohnFry,bothwellknownGPswitha
special interest in the subject, summarized the GPs’ dilemma of whether or notto prescribe
antibiotics:
The core of the problem of treatment of acute infective chest disease in general practice is deciding
when antibacterial therapy should be given ... it is not necessary or desirable to treat minor
catarrhal infections which will recover without antibacterial agents, but a practitioner does not wish
to prejudice his patient’s recovery by failing to institute such treatment when necessary. It is
therefore natural that the practitioner will err on the side of over-prescribing rather than under-
prescribing ...
76
Robson, a hospital chest specialist, in his 1958 review of acute bronchitis advocated early
antibiotics:
Some authorities state categorically that antibiotic treatment is not called for in this type of
disorder. On the other hand bacterial invasion, if not a primary feature, is highly likely to come
in as a secondary one and there is everything to be said for building up a blood level
prophylactically. On the whole this consideration outweighs others and if the disturbance is a
really acute and widespread one with fever, it is wise to get started with antibiotic treatment on
the first or second day. One of the so-called ‘‘wide spectrum’’ preparations should be chosen ...
tetracycline and oxytetracycline are good first choices.
77
This increased pressure to use antibiotics, even the newer ones, was also expressed in a
discussion between the GPs John Horder and John Fry, and Neville Oswald, a hospital
chest specialist, about the acute chest in 1963. Horder was asked about his policy with
antibiotics for the acute chest, and responded:
I tend increasingly to give antibiotics ...we ...know that [patients] get better quicker if they have
an antibiotic. One feels that giving an antibiotic may influence the likelihood of another attack ...it
is this that compels me to give antibiotics more and more regularly and earlier and earlier ... I
almost always use tetracycline ...not penicillin.
78
Evident here is the prophylactic as well as therapeutic use of antibiotics. Yet by 1971, the
British National Formulary had firmly turned away from a widespread recommendation
for antibiotic use. GPs were advised:
The enormous success of antibiotics has lead to such extensive use that ...their value is ...being
lessened ... doctors should not be obliged to give an antibiotic just because there are signs of
infection. Many common illnesses are due to viruses for which antibiotics are useless—even if
bacterial it may well be trivial and self-limiting.
79
Such usage in the 1960s seems surprising given the long-running concern about the
link between ‘‘over prescription’’ and the side effects, resistance and cost of antibiotics.
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The Changing Management of Acute Bronchitis in Britain, 1940–1970Ironically, one important factor in the increased use of antibiotics was the perceived safety
and doctors’ dependence on them for minor ills. This feeling was well summed up in the
commentary which accompanied a symposium on antibiotics published in the Practitioner
in 1956:
The exceptional safety of penicillin put us off our guard. The impression was created that antibiotic
therapy could be applied with impunity. Time has shown that this is not so. Not a single antibiotic
introduced subsequent to penicillin has rivalled it in non-toxicity. ...If the community is to obtain
the full benefit of the tremendous advantages bestowed upon humanity by the discovery and
development of antibiotics, it is essential that these preparations should be used correctly and with
circumspection.
80
The problem of penicillin resistance had been apparent by the late 1940s and data from
the USA illustrated the alarming rise in resistance to newer antibiotics, particularly
amongst staphylococci.
81 Over a two-year period from 1951, penicillin resistance for
staphylococci was around 60 per cent, whilst streptomycin resistance rose from 48 per
cent to 65 per cent, chlortetracycline resistance from 23 per cent to 63 per cent, and
erythromycin resistance from zero to nearly 20 per cent in one year.
82 This was brought
to the public’s attention by, for example, The Times’ headlines, ‘‘Doctors’ warnings on
antibiotics. Organisms becoming resistant’’, when reporting the condemnation of the
indiscriminate use of antibiotics by the BMA in 1956.
83
Debates amongst doctors in the 1940s related primarily to the value of the traditional
management methods, and then in the 1950s switched to decisions about when to start
antibiotics and which one to chose. The advice in textbooks and formularies shows a clear
shift towards bacterial infection being seen as the treatable cause of acute bronchitis, with
antibiotics as the treatment of choice. There was a move away from recommendations of
regimens of bed rest, diet and fluids, symptomatic therapies and slow convalescence, first
to the use of antibiotics in more serious cases to treat complications, and then to their early
use to lessen the symptoms and prevent complications. Thus, acute bronchitis changed
from a potentially dangerous condition with a slow recovery, to one where doctors and
patients expected a safe and prompt recovery, brought on by antibiotics. The change in
treatment protocols was likely to have been popular with the patient, his or her family and
the doctor, as it would have been perceived to reduce the duration, labour and cost of the
traditional regimens.
84 The increasing use of oral antibiotics in the mid- and late 1950s,
instead of the injections and inhalation that were the main forms of administration for
the first decade of penicillin treatment for chest diseases, added further to the attraction of
the antibiotic ‘‘quick fix’’. It was not until the late 1950s that advances in laboratory
techniques for identifying viruses showed that they were important causes of acute
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John T Macfarlane and Michael Worboysrespiratoryillness.
85Theideathatviruseswereimplicatedinmanycasesofcoldsandacute
chesty coughs heralded a progressive shift of opinion in the 1960s that most acute respira-
tory illnesses were viral and not bacterial in origin and, as such, would not respond to
antibiotics, which were largely unnecessary. Indeed, in the 1970s the thirteenth edition of
the American Cecil–Loeb textbook of medicine acute bronchitis was no longer listed in the
index as a distinct entity, instead it appeared as one syndrome of respiratory illness caused
by a variety of viruses.
86 A slower change of emphasis in aetiological thinking was also
evident in British textbooks. In the twelfth edition of the Textbook of medical treatment in
1971, acute bronchitis was described as acute inflammation ‘‘caused by virus or bacterial
infections’’.
87 However, by then, the habit of using antibiotics for acute bronchitis and
acuterespiratorysymptomshadbeen acquiredbybothpatientsandGPs,andwasnoteasily
broken.
Issues in the Management of Acute Bronchitis
The shift towards prescribing antibiotics for all patients with acute bronchitis was not
wholly shaped by clinical experience and research findings, it was affected by, and itself
affected, wider trends in medicine in the post-war decades. Our research found that three
factors were particularly important: the NHS, the pharmaceutical industry, and the emer-
gence of the consumer-patient. In making these points, we show how the policies, orga-
nizational structures and dynamics between the NHS and the pharmaceutical industry
identified at the national level by historians, affected specific local practices with a single
disease.
88
The NHS: Structures and Policies
Costs and work pressures were key factors influencing the use of antibiotics in general
practice.TheunexpecteddemandforservicesthatfollowedthebirthoftheNHSresultedin
an increased burdenof work and a huge overspend on the estimated GP costs. When noting
a 13 per cent rise in workload over the first two years of the Service, the Chief Medical
Officer commented:
Reports received from all quarters [confirm] that the general public has not been backward in taking
advantage of free consultation and free medicine....Assuming that some of this increase is due to
the opportunities presented to those whose faith in the virtue of the bottle of medicine or box of
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The Changing Management of Acute Bronchitis in Britain, 1940–1970tablets is unbounded, there still remains the question whether it is in the general interest that more
people should be taking their trivial ailments to the doctor with perhaps the risk of developing a
disease-conscious frame of mind.
89
The biggest increase in consultations was among women under the age of sixty-five, the
very group which subsequent studies showed consulted more frequently for acute respira-
tory illness.
90 This led GPs to develop strategies to cope with their new and excessive
workload, whilst at the same time they were under pressure from the Ministry of Health to
restrict expenditure on prescriptions. The drug bill was one of the greatest expanding costs
of the new NHS, much of this from primary care prescribing. In June 1948, the last month
of the National Health Insurance (NHI) scheme saw 6.8 million prescriptions being dis-
pensed by chemists. By September 1948, this had doubled to 13.6 million.
91 Patients
expected toreceive medicine. In1956–57,J PMartin investigated whyup tothree-quarters
of medical contacts resulted in a prescription; he found that there was an expectation on
both sides, and from both NHI ‘‘panel’’ and private patients, ‘‘that the prescription fre-
quency was ... part of a response to ill-health ... of doctor and patient when illness
occurred’’.
92 However, the new factor was that now neither the patient nor the GP paid for
the medicines, hence the removal of the financial barrier was of particular significance for
the uptake of expensive antibiotic drugs. Antibiotics contributed substantially to the NHS
costs, and by 1956 accounted for 22.7 per cent of the total prescription cost in England and
Wales and a quarter of the total of all prescriptions by 1961.
93 They were marketed almost
exclusively in the more expensive proprietary form.
94 The percentage of proprietary
medicines prescribed was only 7 per cent of total prescriptions in 1947 under the NHI,
18 per cent in 1950, 40 per cent in 1956 and 48 per cent in 1957. In 1958, the Hinchcliffe
Committee singled out proprietary antibiotics (and steroids) as being the major financial
factor in the increasing drug costs for the NHS.
95
GPs were put under increasing pressure by the Ministry of Health to restrict the pre-
scription of expensive items, and exhortations were soon backed up by the threat of
sanctions, though none of these proved particularly effective.
96 In 1951 the Prescribing
Investigations Unit was established to monitor prescribing. This led to about 900 GPs
being visited each year by their Regional Medical Officer to enquire about their drug
costs, and some GPs were fined up to £100 by their Local Medical Committee for excess
prescribing.
97 Another response to the rising drugs bill was to introduce prescription
charges, which led to Bevan’s resignation in 1951 and the removal of the post of
Minister of Health from the Cabinet. However, we suggest it was not the introduction
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John T Macfarlane and Michael Worboysof the one shilling charge per script in 1952 that was critical in reshaping prescribing
practice, but the intended cost-saving decision in 1956 to charge a shilling per item.
98
Ironically, this seems to have encouraged the use of (expensive) antibiotics in the
treatment of acute bronchitis. GPs had previously added antibiotics to the cheap sympto-
matic remedies on a multi-item script, now they chose what they saw as the single most
effective medication (and also the most expensive). Given the medical and public
concerns about pneumonia and the wish to avoid prolonged illness, it was predictable
that an antibiotic became the treatment of choice. The move towards antibiotics and
away from symptomatic prescriptions happened earlier in the USA. In 1952–1953,
nearly 20 per cent of all prescriptions from the USA were for antibiotics compared
with 8 per cent in England and Wales. The reverse was true for cough preparations,
which amounted to only 5 per cent of prescriptions in the USA but over 17 per cent in
England and Wales at that time.
99 By 1959, only six years later, the number of pre-
scriptions in England and Wales for antibiotics now matched almost exactly those for
cough preparations, although the total cost of the cough mixtures was only 4.5 per cent
of the total prescription budget compared with 28 per cent for antibiotics.
100
List sizes and consultation rates increased after 1948 and work pressure on GPs was
considerable.
101 In 1953, Stephen Taylor found consultation rates of up to ten per listed
person per year, particularly in industrial and urban areas, where list sizes and morbidity
were also higher. Surgery consultations numbered between fifteen to fifty and home
visits twelve to thirty per day with the average consultation time being less than five to
six minutes.
102 Thus, patient pressure was considerable and consultation time was short,
particularly in the winter when bronchitis, coughs, colds and influenza were so common.
It is unsurprising that antibiotics, which offered a quick fix, emerged as the preferred
choice for a self-limiting condition such as acute bronchitis, when put against the time
taken for the doctor to explain the traditional management and natural history of
bronchitis with the somewhat complex regime of symptomatic care and convalescence.
The capitation scheme introduced with the NHS, where the GP was paid by the size of
his list (to a maximum of 5000 patients), put some financial pressure on the GP to keep
list sizes high. This may also have contributed further to antibiotic prescribing for two
reasons. Firstly, giving the new ‘‘miracle drugs’’ could have been a strategy to keep the
patient happy and on the GP’s list; secondly, large lists, which were common in urban
practices, were associated with increased consultation rates per patient, less time per
consultation and increased prescribing.
103 Dr Lennox Johnston from Wallasey brought
out the first issue in the Lancet in 1950, stating, ‘‘The most important factor in the
debasement of general practice is ... competition between general practitioners for
goodwill. The patient can and often (I might almost say usually) does bring economic
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The Changing Management of Acute Bronchitis in Britain, 1940–1970pressure to bear on his general practitioner, in order to secure the type of medical
treatment he wants.’’
104 As Taylor put it in his book Good general practice, which
surveyed life in general practice in 1954, ‘‘The doctor with the over-crowded surgery,
who is always so rushed he never has time to examine properly any of his patients, is
continually doling out placebos for improperly diagnosed conditions.’’
105 Dr Strong, a
GP from Kent, put it another way in a letter to the Lancet in 1950, ‘‘At one end of the
scale are the men with small practices, suffering financial hardship but trying to practice
good medicine ...at the other end are the four-thousand odd being given the best service
that can be expected from overworked and harassed doctors. Quality brings bankruptcy:
quantity has some financial reward.’’
106
In 1958, the Council of the College of General Practitioners, in submitting their report to
the Hinchcliffe Committee on the cost of prescribing, forcefully made the point that
undergraduate and newly qualified doctors did not receive adequate experience of the
common, self-limiting conditions which made up the greater part of a family doctor’s
work.
107Unlikethesituationnowadays,nationallyagreed,clinicalmanagementguidelines
for common conditions aimed specifically at general practitioners were not available.
Acute bronchitis would have been a good example of such a common condition, one
thathospitaltraineddoctorshadneverseenduringtheirtraining,butwouldtreat,relyingon
a simple approach of ‘‘infection equals antibiotics’’. Antibiotics were certainly commonly
used by hospital doctors—in some hospitals up to 40 per cent of the drug budget was spent
on them in 1954.
108 However, in view of the vastly greater number of prescriptions used in
general practice, the direct financial and ecological impact was much less then, and it is
only relatively recently that hospital acquired ‘‘superbugs’’ have caused concern. In 1957,
JohnFrynotedthat£10millionayearwerespentbyGPsonantibioticscomparedwithonly
£2 million spent by hospitals.
109
The Pharmaceutical Industry
Over the 1950s, the standard, proprietary products of the pharmaceutical industry
displaced the individually made-up prescriptions by the dispensing chemist as the main-
stay of medical treatments. Indeed, the rise in the cost of the proprietary medicines was
the main cause of the spiralling NHS drug bill, especially for new antibiotics.
110 For
instance, the cost of a single day’s treatment of chloramphenicol in 1951 was 22s 6d,
about seven times the average cost of a prescription.
111 In the House of Commons debate
on the proposed prescription charge on 27 March 1952, Aneurin Bevan stated that the
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John T Macfarlane and Michael Worboysmain reason for the rise in drug expenditure was the use of new and expensive antibiotics
by the ‘‘ill-disciplined’’ medical profession. A Labour colleague Dr Edith Summerskill
blamed ‘‘high powered salesmen, on behalf of the drug manufacturers ... persuading
doctors to prescribe expensive proprietary drugs for their more well-to-do patients ...the
most flagrant abuse ...by the better-off section of the community at the expense of the
worse-off’’.
112 GPs were certainly targeted by the drug companies. On average, each GP
saw two to three representatives each week and received seven mailings of drug promo-
tional literature every day, occupying over half of his total daily post delivery.
113
Medical organizations had not escaped criticism either. When Dr Charles Brooke
from Mottingham wrote to Aneurin Bevan on 10 November 1949 regarding ‘‘this
Bevan bob business’’, he blamed the BMA and the Medical Protection Union as ‘‘aiders
and abetters in the racket [of drug sales in the UK]’’ due to the enormous revenues that
they were getting through advertisements in their journals, noting that the latter would be
ruined if it refused such advertisements.
114
The changes in the number and type of advertisements carried by the British Medical
Journal show the increase in the ‘‘information’’ targeted at doctors. In the four issues in
January 1949, there were eight antibiotic advertisements, one being a full page, of which
five were for penicillin, including three forpenicillin chewing-gum. Over the four issues in
December 1953 there were twenty-three antibiotic ads: fifteen of them whole pages and
nine for non-penicillin preparations, mostly tetracyclines. For the same period in 1962
there were thirty-three whole page advertisements for antibiotics, with less than half for
penicillin.
The annual reports of the Association of the British Pharmaceutical Industry (ABPI)
show the industry’s unhappiness about the criticism it received for excess expenditure on
advertising and promotion. The first publishedfigures from1961revealed that the industry
spent just over 12 per cent of the revenue from home sales of prescription medicines on
advertising and promotion. In 1963 this amounted to £8.9 million, with £4 million being
spent on drug representatives, £1.3 million on advertising in medical journals, £2.0 million
on mail shots, £0.9 million on other marketing activities and £0.8 million on free
samples.
115 The industry justified this large expenditure and answered the criticisms
about its activities by presenting the pharmaceutical companies as an important source
of medical information for the medical and pharmaceutical professions to ensure ‘‘the
physicianisgivendetailed scientificinformationontheirproperuse’’.
116Itrecognizedthat
the GP had great difficulty in keeping up to date with these advances, often being depen-
dent on drug company representatives or promotional literature in the absence of any
formal professionally organized postgraduate education.
117
The doctors’ freedom to prescribe on the NHS whatever they considered best
inevitably encouraged extravagant sales propaganda and pressure, much of it being
112The Times, 28 March 1952, p. 4.
113AssociationofBritishPharmaceuticalIndustry
(hereafter ABPI), Annual report. 1964–5, London,
ABPI, 1965, p. 13.
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115See ABPI op. cit., note 113 above, p. 13.
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117RCGPA, op. cit., note 32 above, p. 3.
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The Changing Management of Acute Bronchitis in Britain, 1940–1970seen as ‘‘undesirable’’, particularly when the down side of the products was not men-
tioned. When Dr Batten reported to a meeting at the Royal Society of Medicine in 1955
that toxicity was being increasingly reported in the medical press for the newer antibiotics,
she added, ‘‘though you would never think so from the advertisements’’.
118 Certain phar-
maceutical company literature was not all promotional; for example, information sheets
produced for the medical and pharmaceutical professions about penicillin, and about
‘‘coughs and colds’’ by Boots Pure Drug Company in 1950, gave no hint that antibiotics
should be used for non-severe respiratory illnesses such as acute bronchitis.
119 Companies
also claimed that they needed good sales and profits to invest in research and development
for tomorrow’s drugs. However, subsequent annual reports show a change of emphasis
and by 1966–67 the ABPI was seeking professional accreditation and legitimization for
representatives.
120
Patients or Consumers
That patients expected a prescription when visiting their doctor came partly from
custom, partly from their pre-1948 role as purchasers of health care as insurance sub-
scribers or private patients, and partly from the behaviour of the medical profession. The
Council of the College of General Practitioners in its evidence to the Hinchcliffe Com-
mittee admitted that,
In many cases the patient’s expectation that a medicine will be prescribed must be met ... his
sympathy and understanding must often be reinforced by the exhibition of a tangible token. Many
patients would be generally disturbed by their doctor’s failure to prescribe ...even an intelligent
patient, who in health will readily agree that drugs were inadvisable, when he falls sick will often
feel much happier if his doctor gives him something.
121
It is probable that from the late 1940s to the mid-1950s, many doctors prescribed the
least effective oral penicillins and other oral antibiotics as these were less demanding of
their time, and that they reserved injected penicillins for more serious illnesses that also
demanded monitoring.
Public information on antibiotics was available from many other sources including
health encyclopaedias and dictionaries, medical and government publications, articles
in the popular press and magazines, and radio and television programmes. There was
even a horse called ‘‘Aureomycin’’ which ran in the Hambleton Plate at Thirsk Racecourse
on 14 April 1950.
122 Encyclopaedias on family health would certainly have raised public
expectations. For example, the 1956 Good Housekeeping’s encyclopaedia of family health
stated that, ‘‘antibiotics have given man almost complete mastery over disease caused by
micro-organisms’’; also commenting, ‘‘pure penicillin is so powerful that one grain in one
118Joint Meeting, op. cit., note 56 above, p. 359.
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John T Macfarlane and Michael Worboysthousand gallons of water is fatal to some bacteria, whereas a man could take half an
ounce without the least harm’’.
123 However, neither this nor other popular family health
books of the time specifically recommended antibiotics for treating acute bronchitis.
Instead, they merely described the condition as one of potentially protracted duration,
typicallystating, ‘‘thecourseof the illnessisvariable from seven to fourteen days—though
cough, expectoration and debility may last for several weeks’’; and in The book of health,
‘‘It is possible for [the] symptoms to become much more severe and to last for three or
four weeks or longer. It often follows the common cold.’’
124 This would have been
depressing reading for those persons afflicted with the early symptoms, particularly
when the advice was to seek bed rest, light diet, steam inhalations, the ‘‘bronchitis kettle’’,
aspirin and proprietary cough mixtures. Might such advice have encouraged patients to
consult their GP to get one of the new wonder antibiotics in the hope of alleviating or
shortening their distress?
The message in the information in publications produced by, or speaking for, the
medical profession was, as one might expect, more measured. The 1955 edition of
Black’s medical dictionary, which was aimed at a medically-informed audience, advised
penicillin or sulphonamides for troublesome bronchitis symptoms, while still recom-
mending a steam kettle and bed rest in a warm room for mild acute bronchitis, accom-
panied with an illustration of the bronchitis tent.
125 Another medically sanctioned
publication, the Family Doctor, launched in April 1951 by the BMA to provide the
public ‘‘in straight forward English the advice and guidance of doctors who know what
they are talking about’’, included items on ‘‘Is your medicine really necessary?’’ and
‘‘Are you a human medicine bottle?’’, which appeared in the early editions. In the first of
these articles, Dr W Edwards told the public, ‘‘Next time you have to consult your
doctor, pay much more attention to the advice he gives you, and much less to the
prescription form. Pin your faith on his experience ...not on the coloured mixture.’’
126
Dr C Brogan, when seeking an explanation for ‘‘the frantic medicine tippling that has
infected the National Health Service with financial dropsy’’, argued that the public had
come to value the ‘‘bottle’’ as a sign of interest from the doctor. Failure to prescribe was
interpreted wrongly as an ‘‘unkindly hint that the patient was not really ill’’.
127
Articles on bronchitis that appeared in the 1952 and 1953 volumes of Family Doctor
stressed that bed rest and not antibiotics was important.
128 One article took the form of a
dialoguebetweenapatientwithacutebronchitisandhisGP,andgaveaninterestinginsight
into the consultation dynamics at that time. When asked whether he had been coughing
much, the patient comments, ‘‘Yes ...The wife was getting fed up on account of it—said I
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124G Somerville (ed.), Newnes family health
encyclopaedia, London, George Newnes, 1959, p.
112;RLClark,RWCumley(eds),Thebookofhealth:
a medical encyclopedia for everyone, Princeton, Van
Nostrand, 1962, p. 135.
125W A R Thomson, Black’s medical dictionary,
22nded.,London,AdamandCharlesBlack,1955,pp.
143–5.
126W Edwards, ‘Is your medicine really
necessary?’, Family Doctor, 1951, 1: 259–61,
p. 261.
127C Brogan,‘Are you a humanmedicinebottle?’
Family Doctor, 1952, 2: 428–30, p. 429.
128D Tavistock, ‘Family doctor speaking about
bronchitis’,FamilyDoctor,1952,2:600–1;‘Allabout
bronchitis’, Family Doctor, 1953, 3: 158–9.
69
The Changing Management of Acute Bronchitis in Britain, 1940–1970would have to come to see you.’’ The doctor recommends a few days in bed. The patient
becomes concerned because of the effect on his job and asks, ‘‘You couldn’t give me
something to clear it up right away, doctor. I mean like one of those new drugs.’’ The GP
retorted, ‘‘Most of these wonder drugs, as they call them, don’t work at all on the sort of
bronchitis you’ve got. You’ll just have to nurse it and look after it. You take my advice and
you’llbeallrightinafortnightorthreeweeks....ifyougoon...strugglingtowork,you’ll
end up with a really bad chest.’’
129
There is evidence of pressure from patients to prescribe antibiotics. Writing to the
College of General Practitioners in 1956, Dr Byrne, a GP from Milnthorpe, placed the
blame for increased prescribing on the direct advertising of drugs to the public, along
with health education articles in the press and programmes on radio and television.
130 Dr
Ashworth from Manchester, by contrast, wrote, ‘‘I do not accept much pressure from
patients ... Doctors must be prepared to lose a few patients in order to preserve their
proper ethical standards’’.
131 Such comments from individual doctors need to be treated
with caution as the interaction between patient and doctor in this regard is known to be
complex.
132 The Reader’s Digest featured high on critics’ list of offending journals in
this respect, possibly unfairly as, alongside articles praising the safety and efficacy of
penicillin, there was, in July 1953, an article entitled ‘‘Are you overdosing with anti-
biotics?’’ This stated that, ‘‘Antibiotics are no cure-alls ...too many of us summon these
drugs against a mild self limiting disease ...We use them to try and cure a feverish
cold’’. The author went on to warn about the development of resistance ‘‘you are
hastening the day when the wonder drugs will have lost their punch’’, and concluded,
‘‘your Doctor [is] more wary of their [antibiotic] indiscriminate use. Free of your
prodding, he will be more selective and more accurate in his treatment’’.
133
A 1961 Foyle’s Health Handbook on Coughs, colds and bronchitis by Dr Kenneth
Hutchin described acute bronchitis as ‘‘an acute infection of the bronchial tubes’’,
often when a cold ‘‘has gone down on to the chest’’. He added that, ‘‘When it does
follow on from a cold it is most likely that the cause ...is some germ which has been
superimposed on the original cold infection, because bronchitis is usually due to a bacteria
rather than a virus’’. The author recommended ‘‘old-fashioned measures’’ of bed rest,
nursing, and symptomatics (Friar’s Balsam) comfort, which he said aided the effects
of antibiotics. He justified the use of antibiotics (especially the oral administration of
teramycin and achromycin) on the grounds that they reduced the number of cases
that might eventually need hospital care and hence were the most cost-effective
treatment.
134
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In this article we have argued that there was a revolution in the treatment of acute
bronchitis over the 1950s, as antibiotics rapidly replaced symptomatics as the primary
form of treatment. We have shown that this change certainly did not occur because of the
efficacy of the new drugs, as there was little evidence then or now that antibiotics
significantly alter the course or duration of acute bronchitis for the majority of
patients.
135 Instead, we have shown that changes in the treatment of the disease
were due to interrelated epidemiological, clinical, educational, social, political, economic
and industrial pressures. The evidence presented here suggests that antibiotics were first
adopted to treat or prevent secondary complications, such as pneumonia, rather than for
the primary disease. Epidemiologically, acute bronchitis was amongst the most prevalent
illnesses in the 1950s and one of the most common reasons for seeing the doctor, which
gave it a high profile in debates about the problems and future of general practice.
Clinically, there was a dialectical relationship between the changing understanding of the
aetiology and pathology of acute bronchitis and available treatments, especially as the
properties of antibiotics encouraged doctors to shift from a symptomatic to an aetiolo-
gical definition of the condition. Indeed, it seems that the adoption of antibiotic therapy
encouraged doctors to see bacteria as the primary cause of acute bronchitis, even though
there were few studies of the role of specific bacteria and growing evidence pointing to a
greater role for viruses. The structures of the new NHS and the fact that health care was
free at the point of delivery meant that GPs saw more patients and hence more acute
bronchitis than ever before. Increased work loads and unsocial long hours, along with
poor pay and conditions led to low morale amongst GPs, who, while struggling to keep
their heads above water were faced with wave after wave of innovations, with little
opportunity to keep up to date with the rapidly changing therapeutic advances, except via
pharmaceutical company promotions. In such circumstances, it seems that GPs were
more susceptible to seek quick fix antibiotic remedies, both to treat patients presenting
with infections and to prevent their return with persistent disease. Such practices would
have also met patient demands, both for the traditional token of a prescription—the
‘‘bottle’’—and for the most advanced and effective medicine of the day, and encouraged
them to stay on the GP’s list. Also, the political pressures to reduce costs led to a per
script charging regime which paradoxically probably served to raise costs by leading
doctors to prescribe what they and their patients saw as the single most effective drug.
What does the changing management of acute bronchitis tell us about the alleged
‘‘antibiotic revolution’’? To begin with it is clear that antibiotics came to dominate the
treatment of the disease, however, this change occurred in an evolutionary manner over a
decadeorso. Moreover,thereweretwostagestothistakeover,with antibiotics usedfirst to
prevent and treat serious, secondary chest infections, before dominating as a treatment of
primary disease. We have also demonstrated the often overlooked point that antibiotics
135There were no studies or trials that
demonstrated the efficacy of antibiotics in acute
bronchitis, as there was with streptomycin and
tuberculosis. A Yoshioka, ‘Use of randomisation in
the Medical Research Council’s clinical trial of
streptomycininpulmonarytuberculosisinthe1940s’,
Br. med. J., 1998, 317: 1220–23.
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The Changing Management of Acute Bronchitis in Britain, 1940–1970were notasinglestablecommodity,their propertieschangedconstantlyasnew entitiesand
new modes of administration were introduced. Among the most important was the avail-
ability of oral administration which allowed a change in the doctor–patient relationship
through the self-administration of antibiotics, and it was perhaps no accident that this
coincided with the shift to ‘‘antibiotics for all disease’’. Increasing choice of type also saw
the practice of trying a second antibiotic if recovery was not fast enough with the first,
cementing further the dependence on such treatment. We have also shown that changes in
the use of antibiotics were closely linked to changes in NHS policies on prescription
pricing. The most radical changes overall were perhaps the most general; namely, the
way that the use of antibiotics led doctors to think aetiologically about acute bronchitis and
progressively redefine it largely as a bacterial infection, amenable to single-fix, antibiotic
treatments. This attitude persisted through habit by both doctors and patients, even after
researchidentified virusesasthemostcommonaetiologicalagentsinthe1970s,andexpert
opinion and clinical guidance advised against the routine use of antibiotics for acute
bronchitis.
The habit of prescribing antibiotics for acute bronchitis persists today. Patients still visit
their GP in large numbers for common symptoms such as cough (with nearly two million
consultations for acute bronchitis annually in England and Wales) and GPs cope by using a
strategy of prescribingantibiotics for the majorityof cases. In1994, the AuditCommission
judged antibiotic prescriptions in the community for respiratory tract infection to be the
most important factor contributing to the increasing problems of antibiotic resistance, side
effects and cost to the community.
136 Ironically, a recent successful move to reduce GP
antibiotic prescribing has been putatively linked to a rise in morbidity and mortality from
respiratory infections, suggesting that the circle is beginning to turn back towards pre-
antibiotic days and that we need to learn lessons from the 1950s on how to decide which
patients need antibiotics—the older, those with underlying disease, those with localizing
signs ofpneumonia inthe chest, and those illenough tobe inbed.
137Itisinteresting tonote
that this approach was recommended for the use of antibiotics during an influenza pan-
demic in the guidelines produced by the Chief Medical Officer in2006, further evidence of
a return to fifty-year-old practices for the appropriate and targeted use of antibiotics for
acute chest infections.
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